Search - tctmd.com

Displaying 1 - 20 of 14670

Sort: Relevancy | Date

News Daily News

Patient-Surgeon Sex Mismatch Doesn’t Drive Disparities in Cardiac Surgery

Caitlin E. Cox

April 21, 2026

News Daily News

Shock Patients Treated With MCS Devices at Referral Hospitals Have Higher Risks

Michael O'Riordan

April 20, 2026

News Opinion CV Team Dispatch

April 2026 Dispatch for the CV Team

L.A. McKeown

April 17, 2026

News Daily News

For CVD Patients, Calcium Supplements May Spur Recurrent Events

Caitlin E. Cox

April 17, 2026

News Daily News

Women Less Likely Than Men to Adhere to Post-ACS Medications: TEXTMEDS

Michael O'Riordan

April 13, 2026

News Daily News

No Sustained Benefit of High-Flow Nasal Oxygen After Cardiac Surgery: NOTACS

L.A. McKeown

April 13, 2026

News Daily News

CTO PCI Reduces Symptoms, Improves Quality of Life: Meta-analysis

Michael O'Riordan

April 09, 2026

News Conference News ACC 2026

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

Todd Neale

April 02, 2026

News Conference News ACC 2026

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

Michael O'Riordan

April 01, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

Caitlin E. Cox

April 01, 2026

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

News Conference News ACC 2026

Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI

Yael L. Maxwell

March 30, 2026

Presentation ACC 2026

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

Presenter: Nicholas Marston

March 30, 2026

Presentation ACC 2026

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Presenter: Shao-Liang Chen

March 30, 2026

News Conference News ACC 2026

ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial

Michael O'Riordan

March 29, 2026

News Conference News ACC 2026

Noninvasive FFR Measures Match Wire-Based Assessment: ALL RISE and FAST III

L.A. McKeown

March 29, 2026

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

News Conference News ACC 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Michael O'Riordan

March 29, 2026

Presentation ACC 2026

Controlled trial of High-risk coronary Intervention with Percutaneous left ventricular unloading (CHIP-BCIS3)

Presenter: Divaka Perera

March 29, 2026

Presentation ACC 2026

Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina – (ORBITA-CTO) A randomized, placebo-controlled trial

Presenter: Sarosh Khan

March 29, 2026

Advertisement

Patient-Surgeon Sex Mismatch Doesn’t Drive Disparities in Cardiac Surgery

Shock Patients Treated With MCS Devices at Referral Hospitals Have Higher Risks

April 2026 Dispatch for the CV Team

For CVD Patients, Calcium Supplements May Spur Recurrent Events

Women Less Likely Than Men to Adhere to Post-ACS Medications: TEXTMEDS

No Sustained Benefit of High-Flow Nasal Oxygen After Cardiac Surgery: NOTACS

CTO PCI Reduces Symptoms, Improves Quality of Life: Meta-analysis

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

TCTMD’s Top 10 Most Popular Stories for March 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial

Noninvasive FFR Measures Match Wire-Based Assessment: ALL RISE and FAST III

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Controlled trial of High-risk coronary Intervention with Percutaneous left ventricular unloading (CHIP-BCIS3)

Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina – (ORBITA-CTO) A randomized, placebo-controlled trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content